Wells Fargo & Company »

Acelrx Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Acelrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acelrx Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelrx Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $662 901 0.74
2023-09-30 $518 894 0.58
2023-06-30 $1.1k 1.0k 1.11
2022-12-31 $2.2k 975 2.26

More positions owned by Wells Fargo & Company

Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Amazon Put Option (AMZN)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
UnitedHealth Call Option (UNH)
JPMorgan Chase & Co. Put Option (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Johnson & Johnson (JNJ)

View all positions for Wells Fargo & Company

Top funds holding Acelrx Pharmaceuticals

Nantahala Capital Management
Rosalind Advisors
Cantor Fitzgerald, L. P.
Tang Capital Management
Vanguard Group
Values First Advisors
Turtle Creek Wealth Advisors
Virtu Financial
Citadel Advisors
Millennium Management
Jane Street
UBS Group
Advisor Group Holdings
Wells Fargo & Company
Advisory Services Network

View all funds holding Acelrx Pharmaceuticals